Clovis Oncology reported $121.83M in Current Liabilities for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Abbvie ABBV:US $ 32521M 2673M
Acadia Pharmaceuticals ACAD:US $ 119.6M 23.54M
Acorda Therapeutics ACOR:US $ 46M 8.02M
Agenus AGEN:US $ 163.06M 6.12M
Agios Pharmaceuticals AGIO:US $ 45.79M 14.03M
Anika Therapeutics ANIK:US $ 26.99M 2.8M
Arrowhead Research ARWR:US $ 138.86M 1.82M
AstraZeneca AZN:LN 22740M 146M
Astrazeneca AZN:US $ 22740M 146M
Cerulean Pharma CERU:US $ 16.4M 0.34M
Clovis Oncology CLVS:US $ 121.83M 3.38M
Eli Lilly And LLY:US $ 13386M 1666.7M
Enanta Pharmaceuticals ENTA:US $ 30.74M 7.15M
Esperion Therapeutics ESPR:US $ 79.08M 5.73M
GlaxoSmithKline GSK:LN 24278M 608M
Halozyme Therapeutics HALO:US $ 111.69M 5.46M
Heron Therapeutics HRTX:US $ 93M 21.94M
Insmed INSM:US $ 125.25M 9.92M
Intrexon XON:US $ 25.6M 9.04M
Ligand Pharmaceuticals LGND:US $ 42.58M 0.91M
Merk MRK:US $ 22316M 1556M
Mirati Therapeutics MRTX:US $ 123.57M 20.09M
Neurocrine Biosciences NBIX:US $ 253.5M 7.7M
Novartis NOVN:VX SF 29807M 401M
Pfizer PFE:US $ 39268M 3403M
Puma Biotechnology PBYI:US $ 74.79M 34.8M
Rigel Pharmaceuticals RIGL:US $ 59.22M 4.33M
Sangamo Biosciences SGMO:US $ 118.53M 9.36M
Seattle Genetics SGEN:US $ 531.29M 37.56M
Ultragenyx Pharmaceutical RARE:US $ 167.23M 14.14M
Veracyte VCYT:US $ 62.54M 1.61M
YTE INCY:US $ 886.16M 31.86M